Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer;Valeur pronostique de l'immunomarquage du stroma par la MMP-2, la MT1-MMP et le TIMP-2 dans l'adénocarcinome prostatique cliniquement localisé

Progres en Urologie

Volumn 15, Issue 2, 2005, Pages 250-254

  Semaan, Marc ^a   Jovenin, Nicolas ^b   Birembaut, Philippe ^b   Menard, Johann ^a   Staerman, Frédéric ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Metalloproteinases; Prostate cancer; Stage; Stroma

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR;

HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PROGNOSIS; PROSTATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 24344483198     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. AGREN M.S., TAPLIN C.J., WOESSNER J.F., EAGLSTEIN W.H., MERTZ P.M. : Collagenase in wound healing effect of wound age and type. J. Invest. Dermatol., 1992 ; 99 : 709-714
2. ALEXANDER C.M., WERB Z. : Proteinases and extracellular matrix remodelling. Curr. Opin. Cell Biol., 1989 ; 1 : 974-982
3. BOAG A.H., YOUNG I.D. : Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am. J. Pathol., 1994 ; 144 : 585-591.
4. BREW K., DINAKARPANDIAN D., NAGASE H. : Tissue inhibitors of metalloproteinases : evolution, structure and function. Biochim. Biophys. Acta., 2000 ; 1477 : 267-283.
5. BUTLER G.S., BUTLER M.J., ATKINSON S.J., WILL H., TAMUARA T., VAN WESTRUM S.S., CRABBE T., CLEMENTS J., MURPHY G. : The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem., 1998; 273 : 871-880.
6. CHAMBERS A.F., MATRISIAN L.M. : Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 1997 ; 89 : 1260-1270.
7. COCKETT M.I., BIRCH M.L., MURPHY G., HART IR., DOCHERTY A.J.: Metalloproteinase domain structure, cellular invasion and metastasis. Biochem. Soc. Trans., 1994 ; 22 : 55-57.
8. CORNELIUS L.A., NEHRING L.C., ROBY J.D., PARKS W.C., WELGUS H.G. : Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol., 1995 ; 105 : 170-176.
9. CRAWFORD H.C., MATRISIAN L.M. : Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis, 1994 ; 14 : 234-245.
10. D'AMICO A.V., WHITTINGTON R., SCHULTZ D., MALKOWICZ S.B., TOMASZEWSKI J.E., WEIN A. : Outcome based staging for clinically localized adenocarcinoma of the prostate. J. Urol., 1997 ; 158 : 1422-1426.
11. HAN M., PARTIN A.W., ZAHURAK M., PIANTADOSI S., EPSTEIN J.I., WALSH P.C. : Récidive biochimique (antigène spécifique de prostate) suivant la prostatectomie radicale pour cancer prostatique. J. Urol., 2003 ; 169: 517-523.
12. LIGHTNER D.J., LANGE P.H., REDDY P.K., MOORE L. : Prostate specific antigen and local recurrence after radical prostatectomy. J. Urol., 1990 ; 144 : 921-926.
13. LIOTTA L.A. : The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview. Cancer Metastasis Rev., 1990 ; 9: 285-287.
14. LIOTTA L.A., STETLER-STEVENSON W.G. : Metalloproteinases and cancer invasion. Semin. Cancer Biol., 1990 ; 1 : 99-106.
15. MATRISIAN L.M. : The matrix-degrading metalloproteinases. Bioessays, 1992 ; 14 : 455-463.
16. MATTOT V., RAES M.B., HENRIET P., EECKHOUT Y., STEHELIN D., VANDENBUNDER B., DESBIENS X. : Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J. Cell Sci., 1995 ; 108 : 529-535.
17. MONTIE J.E. : Significance and treatment of positive margins or seminal vesicle invasion after radical prostatectomy. Urol. Clin. North Am., 1990 ; 17 : 803-812.
18. MONTIRONI R., FABRIS G., LUCARINI G., BIAGINI G. : Location of 72-kd metalloproteinase (type IV collagenase) in untreated prostatic adenocarcinoma. Pathol. Res. Pract., 1995 ; 191 : 1140-1146.
19. MONTIRONI R., LUCARINI G., CASTALDINI C., GALLUZZI C.M., BIAGINI G., FABRIS G. : Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Anticancer Res., 1996 ; 16 : 2057-2062.
20. MUKAMEL E., DEKEMION J.B., DOREY F., HANNAH J. : Significance of histological prognostic indicators in patients with carcinoma of the prostate. Br. J. Urol., 1990 ;65 : 46-50.
21. MURPHY G., HEMBRY R.M. : Proteinases in rheumatoid arthritis. J. Rheumatol. Suppl., 1992 ; 32 : 61-64.
22. NAGASE H. : Activation mechanisms of matrix metalloproteinases. Biol. Chem., 1997 ; 378 : 151-160.
23. NAGASE H. : Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res., 1998 ; 8 : 179-186.
24. NELSON A.R., FINGLETON B., ROTHENBERG M.L., MATRISIAN L.M. : Matrix metalloproteinases : biologic activity and clinical implications. J. Clin. Oncol., 2000 ; 18 : 1135-1149.
25. POLETTE M., BIREMBAUT P. : Membrane-type metalloproteinases in tumor invasion. Int. J. Biochem. Cell Biol., 1998 ; 30 : 1195-1202.
26. ROSS J.S., KAUR P., SHEEHAN C.E., FISHER H.A., KAUFMAN RA J.R., KALLAKURY B.V. : Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer. Mod. Pathol., 2003 ; 16 : 198-205.
27. SALAMONSEN L.A., NAGASE H., WOOLLEY D.E. : Matrix metalloproteinases and their tissue inhibitors at the ovine trophoblast-uterine interface. J. Reprod. Fertil. Suppl., 1995 ; 49 : 29-37.
28. SATO T., ITO A., MORI Y., YAMASHITA K., HAYAKAWA T., NAGASE H. : Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem. J., 1991 ; 275 : 645-650.
29. SHOFUDA K., MORIYAMA K., NISHIHASHI A., HIGASHI S., MIZUSHIMA H., YASUMITSU H., MIKI K., SATO H., SEIKI M., MIYAZAKI K.: Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. J. Biochem., 1998 ; 124 : 462-470.
30. SMITH D.S., CATALONA W.J. : Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology. 1995 ; 45 : 70-74.
31. STEARNS M.E., WANG M. : Type IV collagenase (M(r) 72,000) expression in human prostate : benign and malignant tissue. Cancer Res., 1993 ; 53: 878-883.
32. STEARNS M..E, STEARNS M. : Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a) expression in human prostate cancer. Oncol. Res., 1996 ; 8 : 63-67.
33. STEARNS M., STEARNS M.E. : Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol. Res, 1996 ; 8 : 69-75.
34. STETLER-STEVENSON W.G., AZNAVOORIAN S., LIOTTA L.A. : Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 1993 ; 9 : 541-573.
35. STILL K., ROBSON C.N., AUTZEN P., ROBINSON M.C., HAMDY F.C.: Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue. Prostate, 2000 ; 42 : 18-25.
36. TRUDEL D., FRADET Y., MEYER F., HAREL F., TETU B. : Significance of MMP-2 expression in prostate cancer : an immunohistochemical study. Cancer Res., 2003 ; 63 : 8511-8515.
37. TUXHORN J.A., AYALA G.E., ROWLEY D.R. : Reactive stroma in prostate cancer progression. J. Urol., 2001 ; 166 : 2472-2483.
38. WALSH P.C. : Radical surgery for prostatic cancer. Cancer, 1980 ; 45 : 1906-1911.
39. WHITMORE W.F. : Locorégional prostatic cancer. Advances in management. Cancer, 1990 ; 65 : 667-674.
40. WOOD M., FUDGE K., MOHLER J.L., FROST A.R., GARCIA F., WANG M., STEARNS M.E. : In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis, 1997.